| Serial Number | 98210542 |
| Word Mark | V |
| Filing Date | Thursday, October 5, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, July 13, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 4, 2026 |
| Pseudo Mark | VOLITION |
| Goods and Services | Chemicals and biological preparations used in industry and science; chemical and biological reagents for use in industry and science; diagnostic reagents for scientific and research purposes; chemical and biological preparations and reagents for use in diagnostic and analytical tests, including in vitro diagnostic laboratory tests, for scientific purposes and not for medical or veterinary purposes; Reagents for scientific use in the field of life sciences; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); assays for testing stem cell differentiation status, other than for medical or veterinary use |
| Indication of Colors claimed | The color coral is claimed as a feature of the mark. |
| Description of Mark | The mark consists of a stylized "V" superimposed over two, coral-colored circles. The shading on the exterior circle goes from light to dark coral. |
| Goods and Services | Medical and therapeutic apparatus and instruments for use in treatment of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS) in humans and animals; Medical and veterinary devices for diagnosing cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs) pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for analyzing and measuring cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in the diagnosis, monitoring and treatment of cancer; medical apparatus, instruments and equipment for use in the monitoring and diagnosis of sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage and inflammation, disorders associated with neutrophil extracellular traps (NETs) and pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in monitoring the immune system, namely, for monitoring blood properties; Medical diagnostic apparatus for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for use with chemical and biological reagents, for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical apparatus for use in carrying out diagnostic assays; Medical apparatus, equipment and instruments for monitoring diseases namely, cancer sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); apparatus for DNA and RNA testing for medical purposes; Medical apparatus for use in regeneration of transplant tissues and organs; blood testing apparatus; dialyzers; apheresis devices for medical use; structural parts for all the aforesaid goods |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 13, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 13, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Belgian Volition SRL |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London EC4A3AF BE |
| Event Date | Event Description |
| Monday, October 9, 2023 | NEW APPLICATION ENTERED |
| Friday, October 13, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, October 14, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 23, 2024 | ASSIGNED TO EXAMINER |
| Monday, June 24, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, June 24, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, June 24, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 4, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, September 4, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, September 4, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 4, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 4, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 11, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, September 11, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, December 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 14, 2025 | SUSPENSION LETTER WRITTEN |
| Tuesday, January 14, 2025 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 14, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, July 15, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, October 6, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, October 6, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, October 6, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 12, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 12, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 12, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 12, 2026 | FINAL REFUSAL WRITTEN |
| Monday, January 12, 2026 | FINAL REFUSAL E-MAILED |
| Monday, January 12, 2026 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, April 2, 2026 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, April 2, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 2, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 27, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, April 27, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, April 27, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 1, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 1, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 1, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 2, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |